Author(s):
Ankit Raju Waghmare, Amruta Bapu Lokhande, Vetal Nana Kodalkar
Email(s):
amrutalokhande642@gmail.com , anketwaghmare2002@gmail.com
DOI:
10.52711/0975-4377.2024.00057 
Address:
Ankit Raju Waghmare*, Amruta Bapu Lokhande, Vetal Nana Kodalkar
Mandesh Institute of Pharmaceutical Science and Reaserch Centre, Mhaswad, Maharashtra, India.
*Corresponding Author
Published In:
Volume - 16,
Issue - 4,
Year - 2024
ABSTRACT:
Since very early times, people have been afflicted by the disease known as tuberculosis (TB). Anti-TB allopathic drugs have been administered to manage the disease's symptoms, but they include side effects such hepatitis, hypersensitivity responses, nausea, and vomiting, among others. Ayurvedic (Indian traditional medicine) and foreign medicinal herbs origin have been used to treat TB with success. In this particular review, turmeric with potential anti-tubercular action were described. curcumin is the principal curcuminoid obtained from the plant curcuma longa and has been extensively studied for its biological and chemical properties, including antimicrobial, anti-inflammatory, antioxidant, and antitumor activity. These include antimycobacterial activity, modulation of the host immune response and enhancement of BCG vaccine efficacy.
Cite this article:
Ankit Raju Waghmare, Amruta Bapu Lokhande, Vetal Nana Kodalkar. Medicinal Effect of Curcumin as an Anti-tuberculosis. Research Journal of Pharmaceutical Dosage Forms and Technology. 2024; 16(4):365-7. doi: 10.52711/0975-4377.2024.00057
Cite(Electronic):
Ankit Raju Waghmare, Amruta Bapu Lokhande, Vetal Nana Kodalkar. Medicinal Effect of Curcumin as an Anti-tuberculosis. Research Journal of Pharmaceutical Dosage Forms and Technology. 2024; 16(4):365-7. doi: 10.52711/0975-4377.2024.00057 Available on: https://rjpdft.com/AbstractView.aspx?PID=2024-16-4-11
REFERENCES:
1. Godreuil S, Tazi L, Banuls AL. Pulmonary Tuberculosis and Mycobacterium Tuberculosis: Modern Molecular Epidemiology and Perspectives. Encyclopedia of Infectious Diseases: Modern Methodologies. 2007; 1: 1-29
2. Joseph P, Severe P, Ferdinand S, Goh KS, Sola C, Haas DW, Johnson WD, Rastogi N, Pape JW, Fitzgerald DW. Multidrug-resistant tuberculosis at an HIV testing center in Haiti. AIDS. 2006; 2(3): 415-418.
3. Sensi P. Approaches to the Development of New Anti-tuberculosis Drugs. Reviews of Infectious Diseases. 1989; 2(2): S467-S470.
4. Sharma SK, Mohan A. Multidrug-resistant tuberculosis. Indian J Med Res. 2004; 120: 354-376
5. Johnson R, Elizabeth MS, Louw GE, Warren RM, Helden PDV and Victor TC. Drug Resistance in Mycobacterium tuberculosis. Curr. Issues Mol. Biol. 2006; 8: 97–112.
6. Sam Burcher and Mae-Wan Ho. Prac. Global Strategy for Traditional Medicine Research.1996; 142144.
7. Drabu, S., Khatri, S., Sheveta, B. and Lohani, P. Use of Herbal Bioenhancers to Increase the Bioavailability of Drugs- A Review. Research Journal of Pharmaceutical, Biological and Chemical Sciences. 2011; 2(4): 107-119.
8. Kesarwani, K. and Gupta, R. Bioavailability enhancers of herbal origin: An overview, Asian Pacific Journal of Tropical Biomedicine. 2013; 3(4): 253-266.
9. Tatiraju, D., Bagade, V., Karambelkar, P., Jadhav, V. and Kadam, V. Natural Bioenhancers: An overview, Journal of Pharmacognosy and Phytochemistry. 2013; 2(3): 55-60.
10. About Antimicrobial Resistance (https://www.cdc.gov/ drugresistance/about.html). www.cdc.gov. retrieved on 16 September 2017.
11. Fixed‐Dose Combinations for HIV/AIDS, tuberculosis and malaria, report of a meeting held from 16‐18 December 2003, World Health Organisation, Geneva.
12. Shishoo CJ et al. Stability of rifampicin in dissolution medium in presence of isoniazid, Int. J. Pharm. 1999; 190: 109-123.
13. Singh S et al. The reason for an increase in decomposition of rifampicin in the presence of isoniazid under acid conditions, Pharm. Pharmacol. Commun. 2000a; 6: 405-410.
14. Seifart HI, Parkin DP and Donald PR. Stability of Isoniazid, Rifampicin and Pyrazinamide in suspensions used for the treatment of tuberculosis in children, Pediatr. Infect. Dis. 1991; 10: 827–831.
15. Singh S et al, Behaviour of uptake of moisture by drugs and excipients under accelerated conditions of temperature and humidity in the absence and the presence of light. 1. Pure anti-tuberculosis drugs and their combinations. Int. J. Pharm. 2002; 245: 37– 44.
16. Purohit SD et al, Dietary constituents and rifampicin absorption, Tubercle. 1987; 68: 151-152.
17. Patwardhan B, Vaidya ADB, Chorghade M. Ayurveda and natural products drug discovery. Current Science. 2004; 86(6): 789- 799.
18. Kurokawa M, Shimizu T, Watanabe W, Shirak K. Development of New Antiviral Agents from Natural Products. The Open Antimicrobial Agents Journal. 2010; 2: 49-57.
19. Hoareau L, DaSilva EJ. Medicinal plants: a reemerging health aid. Electronic Journal of Biotechnology. 1999; 2(2): 56-70.
20. Rosenblatt MB. Pulmonary tuberculosis: Evolution of modern therapy. Bull NY Acad Med. 1973; 49: 163–196.
21. Schatz A, Bugie E, Waksman SA. Streptomycin, a substance exhibiting antibiotic activity against Gram-positive and Gram-negative bacteria. ProcSoc Exp Biol Med. 1944; 55: 66–69.
22. Diacon AH, Pym A, Grobusch M, Patientia R, Rustomjee R, Shipp L, Pistorius C, Krause R, Bogoshi M, Churchyard G, et al. The diarylquinoline TMC207 for multidrug-resistant tuberculosis. N Engl J Med. 2009; 360: 2397–2405.
23. Soleimani V., Sahebkar A., Hosseinzadeh H. Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances. Phytother. Res. 2018; 32: 985–995. doi: 10.1002/ptr.6054.
24. Eke-Okoro U.J., Raffa R.B., Pergolizzi J.V., Jr., Breve F., Taylor R., Jr., NEMA Research Group Curcumin in turmeric: Basic and clinical evidence for a potential role in analgesia. J. Clin. Pharm. Ther. 2018; 43: 460–466. doi: 10.1111/jcpt.12703.
25. Tomeh M.A., Hadianamrei R., Zhao X. A review of curcumin and its derivatives as anticancer agents. Int. J. Mol. Sci. 2019; 20: 1033. doi: 10.3390/ijms20051033.
26. Abrahams S., Haylett W.L., Johnson G., Carr J.A., Bardien S. Antioxidant effects of curcumin in models of neurodegeneration, aging, oxidative and nitrosative stress: A review. Neuroscience. 2019; 406: 1–21. doi: 10.1016/j.neuroscience.2019.02.020.
27. Pivari F., Mingione A., Brasacchio C., Soldati L. Curcumin and type 2 diabetes mellitus: Prevention and treatment. Nutrients. 2019; 11: 1837. doi: 10.3390/nu11081837.